Cargando…
High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma
Due to the therapy resistance and frequent metastasis, pancreatic ductal adenocarcinoma(PDAC) remains one of the most malignant carcinoma. WNT7A, an important ligand of Wnt/β-catenin signaling pathways, has a controversial role in tumor development. The role of WNT7A in PDAC remains unclear. In this...
Autores principales: | Wu, Dong-jin, Jiang, Yong-sheng, He, Rui-zhe, Tao, Ling-ye, Yang, Min-wei, Fu, Xue-liang, Yang, Jiang-yu, Zhu, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202314/ https://www.ncbi.nlm.nih.gov/pubmed/30361522 http://dx.doi.org/10.1038/s41598-018-34094-3 |
Ejemplares similares
-
Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015) -
Corrigendum: Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015) -
Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015) -
The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma
por: Luan, Hong, et al.
Publicado: (2022) -
PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma
por: Ge, Ouyang, et al.
Publicado: (2021)